TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 116 filers reported holding TRILLIUM THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,489,000 | +81.1% | 198,699 | 0.0% | 1.27% | +85.1% |
| Q2 2021 | $1,927,000 | -9.7% | 198,699 | 0.0% | 0.68% | -25.0% |
| Q1 2021 | $2,134,000 | -17.0% | 198,699 | +13.7% | 0.91% | -21.5% |
| Q4 2020 | $2,570,000 | +2.6% | 174,699 | -0.9% | 1.16% | -20.8% |
| Q3 2020 | $2,504,000 | +17.1% | 176,215 | -33.3% | 1.47% | +25.9% |
| Q2 2020 | $2,138,000 | +288.0% | 264,225 | +93.6% | 1.17% | +235.3% |
| Q1 2020 | $551,000 | – | 136,500 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 701,138 | $4,067,000 | 0.67% |
| Matrix Capital Management Company, LP | 2,288,560 | $13,274,000 | 0.33% |
| NEA Management Company, LLC | 1,250,000 | $7,250,000 | 0.31% |
| Stanley-Laman Group, Ltd. | 139,403 | $809,000 | 0.20% |
| Cormorant Asset Management, LP | 500,000 | $2,900,000 | 0.19% |
| Tekla Capital Management LLC | 468,399 | $2,717,000 | 0.10% |
| Wealth Alliance Advisory Group, LLC | 21,800 | $126,000 | 0.06% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 175,339 | $1,007,000 | 0.03% |
| Artal Group S.A. | 150,000 | $870,000 | 0.02% |
| Baker Brothers Advisors | 505,262 | $2,931,000 | 0.02% |